Which hedge funds own IOBTQ? IO BIOTECH INC, Q2 2026 13F holders
0 tracked hedge funds disclosed a position in IOBTQ (IO BIOTECH INC) in their Q2 2026 13F filings, worth $0 in total. 5 exited: Ikarian Capital, LLC, Gsa Capital Partners LLP, Boothbay Fund Management, LLC.
- 0
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 0
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 5
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $0
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $157k
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $0
- Combined value Sum of the holders' reported positions in the security.
- 0.0%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Ikarian Capital, LLC | 0.01% | $81.4k |
| Gsa Capital Partners LLP | 0.0% | $20.0k |
| Boothbay Fund Management, LLC | 0.0% | $26.5k |
| Marshall Wace, LLP | 0.0% | $18.1k |
| Millennium Management LLC | 0.0% | $11.4k |
Ownership over time
Who discovered IOBTQ first? Beta
| Stonepine Capital Management, LLC | Q3 2023 | +0.2 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.